التفاصيل البيبلوغرافية
| العنوان: |
New drugs for atrial fibrillation. |
| المؤلفون: |
Hammwöhner M, Smid J, Lendeckel U, Goette A, Hammwöhner, Matthias, Smid, Jan, Lendeckel, Uwe, Goette, Andreas |
| المصدر: |
Journal of Interventional Cardiac Electrophysiology; Oct2008, Vol. 23 Issue 1, p15-21, 7p |
| مستخلص: |
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Epidemiologic studies suggest that the number of patients with AF will triple in the next 30 years, and therefore, its impact on medical and economic issues will further increase. Due to the limited efficacy and significant side effects of antiarrhythmic drugs, much effort has been made to develop alternative pharmacologic treatments for AF. Novel approaches include new antiarrhythmic drugs and novel drug targets involved in molecular, proarrhythmogenic, atrial remodeling. Furthermore, novel anticoagulants are now clinically studied. This review briefly summarizes new developments in the pharmacotherapy for AF. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Interventional Cardiac Electrophysiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
